Calreticulin Binds to Fas Ligand and Inhibits Neuronal Cell Apoptosis Induced by Ischemia-Reperfusion Injury

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Chen, Beilei ^a,b   Wu, Zhengzheng ^a   Xu, Jun ^b   Xu, Yun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NORTHERN JIANGSU PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETICULIN; CASPASE 3; CASPASE 8; FAS LIGAND; MESSENGER RNA; CASP3 PROTEIN, MOUSE; FAS ANTIGEN; FAS PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN SLICE; CELL SURFACE; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; MALE; MOUSE; MTT ASSAY; NERVE CELL; NEUROPROTECTION; NONHUMAN; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CEREBRAL ARTERY DISEASE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CALRETICULIN; CASPASE 3; CASPASE 8; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MICE; NEURONS; REPERFUSION INJURY;

EID: 84947429862     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/895284     Document Type: Article

References (20)

1. K. Srinivasan and S. S. Sharma, "Augmentation of endoplasmic reticulumstress in cerebral ischemia/reperfusion injury associated with comorbid type 2 diabetes," Neurological Research, vol. 33, no. 8, pp. 858-865, 2011.
2. A.Martin-Villalba, I. Herr, I. Jeremias et al., "CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligandmediate ischemia-induced apoptosis in neurons,"The Journal of Neuroscience, vol. 19, no. 10, pp. 3809-3817, 1999.
3. L. I. Gold, P. Eggleton, M. T. Sweetwyne et al., "Calreticulin: non-endoplasmic reticulum functions in physiology and disease," FASEB Journal, vol. 24, no. 3, pp. 665-683, 2010.
4. J. M. Tarr, P. J. Young, R. Morse et al., "A mechanism of release of calreticulin fromcells during apoptosis," Journal ofMolecular Biology, vol. 401, no. 5, pp. 799-812, 2010.
5. J. Jia, D. Guan, W. Zhu et al., "Estrogen inhibits Fas-mediated apoptosis in experimental stroke," Experimental Neurology, vol. 215, no. 1, pp. 48-52, 2009.
6. A. Rosell, E. Cuadrado, J. Alvarez-Sabn et al., "Caspase-3 is related to infarct growth after human ischemic stroke," Neuroscience Letters, vol. 430, no. 1, pp. 1-6, 2008.
7. K. Duus, R. T. Pagh, U. Holmskov, P. Højrup, S. Skov, and G. Houen, "Interaction of calreticulin with CD40 ligand, TRAIL and Fas ligand," Scandinavian Journal of Immunology, vol. 66, no. 5, pp. 501-507, 2007.
8. J. M. Tarr, P. G. Winyard, B. Ryan et al., "Extracellular calreticulin is present in the joints of patients with rheumatoid arthritis and inhibits FasL (CD95L)-mediated apoptosis of T cells," Arthritis and Rheumatism, vol. 62, no. 10, pp. 2919-2929, 2010.
9. M. Zhang, Q. Li, L. Chen et al., "PSD-93 deletion inhibits Fynmediated phosphorylation of NR2B and protects against focal cerebral ischemia," Neurobiology of Disease, vol. 68, pp. 104-111, 2014.
10. H. Zhao, S.-L. Wang, L. Qian et al., "Diammonium glycyrrhizinate attenuates A(1-42)-induced neuroinflammation and regulates MAPK and NF-B pathways in vitro and in vivo," CNS Neuroscience and Therapeutics, vol. 19, no. 2, pp. 117-124, 2013.
11. J. Li, S. Zhang,M. Lu et al., "Hydroxysafflor yellow A suppresses inflammatory responses of BV2 microglia after oxygen-glucose deprivation,"Neuroscience Letters, vol. 535, no. 1,pp. 51-56, 2013.
12. Z. Zhang, Z.Wu, X. Zhu, X. Hui, J. Pan, and Y. Xu, "Hydroxysafflor yellow A inhibits neuroinflammation mediated by A1-42 in BV-2 cells," Neuroscience Letters, vol. 562, pp. 39-44, 2014.
13. L. I. Gold, P. Eggleton, M. T. Sweetwyne et al., "Calreticulin: non-endoplasmic reticulum functions in physiology and disease," The FASEB Journal, vol. 24, no. 3, pp. 665-683, 2010.
14. S. Mans, Y. Banz, B. U. Mueller, and T. Pabst, "The angiogenesis inhibitor vasostatin is regulated by neutrophil elastasedependent cleavage of calreticulin in AML patients," Blood, vol. 120, no. 13, pp. 2690-2699, 2012.
15. D. H. Shin, E. Lee, H. J. Kim et al., "Fas ligand mRNA expression in the mouse central nervous system," Journal of Neuroimmunology, vol. 123, no. 1-2, pp. 50-57, 2002.
16. T. Imanishi, D. K. Han, L. Hofstra et al., "Apoptosis of vascular smooth muscle cells is induced by Fas ligand derived from monocytes/macrophage," Atherosclerosis, vol. 161, no. 1, pp. 143-151, 2002.
17. W. Wang, T. Wang, W.-Y. Feng, Z.-Y. Wang, M.-S. Cheng, and Y.-J. Wang, "Ecdysterone protects gerbil brain from temporal global cerebral ischemia/reperfusion injury via preventing neuron apoptosis and deactivating astrocytes and microglia cells," Neuroscience Research, vol. 81-82, pp. 21-29, 2014.
18. M. Li, J. Peng, M.-D. Wang, Y.-L. Song, Y.-W. Mei, and Y. Fang, "Passive movement improves the learning and memory function of rats with cerebral infarction by inhibiting neuron cell apoptosis," Molecular Neurobiology, vol. 49, no. 1, pp. 216-221, 2014.
19. F.-N. Niu, X. Zhang, X.-M. Hu et al., "Targeted mutation of Fas ligand gene attenuates brain inflammation in experimental stroke," Brain, Behavior, and Immunity, vol. 26, no. 1, pp. 61-71, 2012.
20. M.Michalak, J. Groenendyk, E. Szabo, L. I. Gold, and M. Opas, "Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum," Biochemical Journal, vol. 417, no. 3, pp. 651-666, 2009.